Eribulin Mesylate

Eribulin is a chemotherapy drug used to treat certain types of cancer, including breast cancer and liposarcoma. It is a microtubule inhibitor that works by stopping cancer cells from dividing and growing.

Brick42, together with partners has a fully developed, synthetic, and non-infringing process for the production of Eribulin API.

For more information please contact